AdaptHealth director receives 18,999-share RSU grant

Weaver Susan T reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Weaver Susan T reported acquisition or exercise transactions in this Form 4 filing.

AdaptHealth Corp. director Susan T. Weaver reported a stock-based compensation award rather than an open-market trade. She received 18,999 shares of Common Stock in the form of restricted stock units at $0.00 per share, bringing her direct holdings to 40,345 shares. A separate line shows 73,472 shares of Common Stock held indirectly through the Susan T. Weaver 2025 Irrevocable Trust, for which her spouse and son are co-trustees and her spouse and children are beneficiaries. The restricted stock units will be settled in common stock upon vesting.

Insider Trade Summary

Grant/Award: 18,999 shares

Grant/Award 2 txns

Insider Weaver Susan T

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,999	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 40,345 shares (Direct); Common Stock — 73,472 shares (Indirect, By Irrevocable Trust)

Footnotes (2)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.
2. F2. Securities held by the Susan T. Weaver 2025 Irrevocable Trust, of which the reporting person's spouse and son are the co-trustees and the reporting person's spouse and children are the beneficiaries.

Key Figures

RSU grant size: 18,999 shares Grant price: $0.00 per share Direct holdings after grant: 40,345 shares +3 more

6 metrics

RSU grant size 18,999 shares Restricted stock units of Common Stock granted

Grant price $0.00 per share Stated price for RSU award

Direct holdings after grant 40,345 shares Common Stock held directly after RSU award

Indirect trust holdings 73,472 shares Common Stock held via 2025 Irrevocable Trust

Acquire transactions 1 transaction Grant/award acquisition count in summary

Holding entries 1 entry Non-transactional holding line in summary

Key Terms

restricted stock units, Irrevocable Trust, grant/award acquisition, indirect

4 terms

restricted stock units financial

"These shares represent restricted stock units and will be settled in common stock upon vesting."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Irrevocable Trust financial

"Securities held by the Susan T. Weaver 2025 Irrevocable Trust, of which the reporting person's spouse and son are the co-trustees"

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

indirect financial

""ownership_type": "indirect""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AdaptHealth (AHCO) director Susan T. Weaver report in this Form 4?

Susan T. Weaver reported receiving 18,999 restricted stock units in AdaptHealth common stock as a grant. These units were awarded at $0.00 per share and increase her direct holdings to 40,345 shares once granted stock is counted.

Was the AdaptHealth (AHCO) Form 4 a stock purchase or sale by Susan T. Weaver?

The Form 4 does not show an open-market purchase or sale by Susan T. Weaver. It reports a grant of 18,999 restricted stock units as compensation, with a stated price of $0.00 per share, rather than a buy or sell transaction.

How many AdaptHealth (AHCO) shares does Susan T. Weaver now hold directly?

After the reported grant, Susan T. Weaver holds 40,345 shares of AdaptHealth common stock directly. This figure reflects her direct ownership position following the award of 18,999 restricted stock units at no cash purchase price.

What AdaptHealth (AHCO) shares are held through the Susan T. Weaver 2025 Irrevocable Trust?

The filing shows 73,472 AdaptHealth common shares held indirectly via the Susan T. Weaver 2025 Irrevocable Trust. Her spouse and son serve as co-trustees, and her spouse and children are the trust’s beneficiaries, indicating these are family-related holdings.

What are the terms of the restricted stock units reported for AdaptHealth (AHCO)?

The 18,999 reported restricted stock units will be settled in AdaptHealth common stock upon vesting. They were granted at a stated price of $0.00 per share, consistent with typical equity compensation awards that do not involve an upfront cash payment by the director.

Does this AdaptHealth (AHCO) Form 4 show any remaining derivative securities for Susan T. Weaver?

The Form 4’s derivative section is empty, showing no reportable options or other derivative securities for Susan T. Weaver. The filing instead focuses on the new restricted stock unit grant and her resulting direct and indirect common stock positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weaver Susan T

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		18,999(1)	A	$0	40,345	D
Common Stock								73,472	I	By Irrevocable Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

2. Securities held by the Susan T. Weaver 2025 Irrevocable Trust, of which the reporting person's spouse and son are the co-trustees and the reporting person's spouse and children are the beneficiaries.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Susan Weaver	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)